(*) EU CE Mark Date: 2022. 05.03
(*) USA Approval Date: 2022. 01.10
(*) USA Launch Date: 2022. 05.02
>Receptor Antagonist Tablets
Company
Generic Name: daridorexant
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2022. 03.08
TM
TM Web-Site